Skip to main content
Erschienen in: International Journal of Legal Medicine 5/2013

01.09.2013 | Original Article

Using bone marrow matrix to analyze meprobamate for forensic toxicological purposes

verfasst von: F. Bévalot, M. P. Gustin, N. Cartiser, Y. Gaillard, C. Le Meur, L. Fanton, J. Guitton, D. Malicier

Erschienen in: International Journal of Legal Medicine | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Bone marrow (BM) analysis is of forensic interest for postmortem toxicological investigations where blood samples are unavailable or unusable. Due to the lack of studies, it remains difficult to interpret concentrations of xenobiotics measured in this matrix. Based on a statistical approach published previously to interpret meprobamate concentrations in bile and vitreous humor, we propose here a diagnostic test for interpretation of BM meprobamate concentrations from analysis of 99 sets of autopsy data. The mean age was 48 years (range 18–80 years, one unknown) for males and 50 years (range 19–80 years, one unknown) for females, with a male/female ratio at 0.768. A BM concentration threshold of 11.3 μg/g was found to be statistically equivalent to that of a blood meprobamate concentration threshold of 50 μg/ml in distinguishing overdose from therapeutic use. The intrinsic qualities of this diagnostic test were good with sensitivity of 0.82 and specificity of 0.92. Compared to previous tests published with the same objective on vitreous humor and bile, this study shows that BM is a useful alternative matrix to reveal meprobamate overdose when blood, vitreous humor, and bile are not available or unusable.
Literatur
2.
Zurück zum Zitat Winek CL, Janssen JK (1982) Blood versus bone marrow isopropanol concentrations in rabbits. Forensic Sci Int 20(1):11–20PubMedCrossRef Winek CL, Janssen JK (1982) Blood versus bone marrow isopropanol concentrations in rabbits. Forensic Sci Int 20(1):11–20PubMedCrossRef
4.
Zurück zum Zitat Winek CL, Costantino AG, Wahba WW, Collom WD (1985) Blood versus bone marrow pentobarbital concentrations. Forensic Sci Int 27(1):15–24PubMedCrossRef Winek CL, Costantino AG, Wahba WW, Collom WD (1985) Blood versus bone marrow pentobarbital concentrations. Forensic Sci Int 27(1):15–24PubMedCrossRef
5.
Zurück zum Zitat Winek CL, Westwood SE, Wahba WW (1990) Plasma versus bone marrow desipramine: a comparative study. Forensic Sci Int 48(1):49–57PubMedCrossRef Winek CL, Westwood SE, Wahba WW (1990) Plasma versus bone marrow desipramine: a comparative study. Forensic Sci Int 48(1):49–57PubMedCrossRef
6.
Zurück zum Zitat Maeda H, Oritani S, Nagai K, Tanaka T, Tanaka N (1997) Detection of bromisovalum from the bone marrow of skeletonized human remains: a case report with a comparison between gas chromatography/mass spectrometry (GC/MS) and high-performance liquid chromatography/mass spectrometry (LC/MS). Med Sci Law 37(3):248–253PubMed Maeda H, Oritani S, Nagai K, Tanaka T, Tanaka N (1997) Detection of bromisovalum from the bone marrow of skeletonized human remains: a case report with a comparison between gas chromatography/mass spectrometry (GC/MS) and high-performance liquid chromatography/mass spectrometry (LC/MS). Med Sci Law 37(3):248–253PubMed
7.
Zurück zum Zitat Kojima T, Okamoto I, Miyazaki T, Chikasue F, Yashiki M, Nakamura K (1986) Detection of methamphetamine and amphetamine in a skeletonized body buried for 5 years. Forensic Sci Int 31(2):93–102. doi:0379-0738(86)90193-3 PubMedCrossRef Kojima T, Okamoto I, Miyazaki T, Chikasue F, Yashiki M, Nakamura K (1986) Detection of methamphetamine and amphetamine in a skeletonized body buried for 5 years. Forensic Sci Int 31(2):93–102. doi:0379-0738(86)90193-3 PubMedCrossRef
8.
Zurück zum Zitat Bal TS, Hewitt RW, Hiscutt AA, Johnson B (1989) Analysis of bone marrow and decomposed body tissue for the presence of paracetamol and dextropropoxyphene. J Forensic Sci Soc 29(3):219–223PubMedCrossRef Bal TS, Hewitt RW, Hiscutt AA, Johnson B (1989) Analysis of bone marrow and decomposed body tissue for the presence of paracetamol and dextropropoxyphene. J Forensic Sci Soc 29(3):219–223PubMedCrossRef
9.
Zurück zum Zitat Noguchi TT, Nakamura GR, Griesemer EC (1978) Drug analyses of skeletonizing remains. J Forensic Sci 23(3):490–492PubMed Noguchi TT, Nakamura GR, Griesemer EC (1978) Drug analyses of skeletonizing remains. J Forensic Sci 23(3):490–492PubMed
10.
Zurück zum Zitat Kudo K, Sugie H, Syoui N, Kurihara K, Jitsufuchi N, Imamura T, Ikeda N (1997) Detection of triazolam in skeletal remains buried for 4 years. Int J Legal Med 110(5):281–283PubMedCrossRef Kudo K, Sugie H, Syoui N, Kurihara K, Jitsufuchi N, Imamura T, Ikeda N (1997) Detection of triazolam in skeletal remains buried for 4 years. Int J Legal Med 110(5):281–283PubMedCrossRef
11.
Zurück zum Zitat Higuchi T, Kogawa H, Satoh M, Tatsuno M, Tsuchihashi H (1996) Application of high-performance liquid chromatography/mass spectrometry to drug screening. Am J Forensic Med Pathol 17(1):21–23PubMedCrossRef Higuchi T, Kogawa H, Satoh M, Tatsuno M, Tsuchihashi H (1996) Application of high-performance liquid chromatography/mass spectrometry to drug screening. Am J Forensic Med Pathol 17(1):21–23PubMedCrossRef
12.
Zurück zum Zitat McIntyre LM, King CV, Boratto M, Drummer OH (2000) Post-mortem drug analyses in bone and bone marrow. Ther Drug Monit 22(1):79–83PubMedCrossRef McIntyre LM, King CV, Boratto M, Drummer OH (2000) Post-mortem drug analyses in bone and bone marrow. Ther Drug Monit 22(1):79–83PubMedCrossRef
13.
Zurück zum Zitat Cartiser N, Bevalot F, Chatenay C, Le Meur C, Gaillard Y, Malicier D, Guitton J, Fanton L (2011) Postmortem measurement of caffeine in bone marrow: influence of sample location and correlation with blood concentration. Forensic Sci Int 210(1–3):149–153. doi:S0379-0738(11)00114-9 PubMedCrossRef Cartiser N, Bevalot F, Chatenay C, Le Meur C, Gaillard Y, Malicier D, Guitton J, Fanton L (2011) Postmortem measurement of caffeine in bone marrow: influence of sample location and correlation with blood concentration. Forensic Sci Int 210(1–3):149–153. doi:S0379-0738(11)00114-9 PubMedCrossRef
14.
Zurück zum Zitat Fanton L, Bevalot F, Gustin MP, Paultre CZ, Le Meur C, Malicier D (2009) Interpretation of drug concentrations in an alternative matrix: the case of meprobamate in bile. Int J Legal Med 123(2):97–102. doi:10.1007/s00414-008-0259-x PubMedCrossRef Fanton L, Bevalot F, Gustin MP, Paultre CZ, Le Meur C, Malicier D (2009) Interpretation of drug concentrations in an alternative matrix: the case of meprobamate in bile. Int J Legal Med 123(2):97–102. doi:10.​1007/​s00414-008-0259-x PubMedCrossRef
15.
Zurück zum Zitat Bevalot F, Gustin MP, Cartiser N, Le Meur C, Malicier D, Fanton L (2011) Interpretation of drug concentrations in an alternative matrix: the case of meprobamate in vitreous humor. Int J Legal Med 125(3):463–468. doi:10.1007/s00414-011-0560-y PubMedCrossRef Bevalot F, Gustin MP, Cartiser N, Le Meur C, Malicier D, Fanton L (2011) Interpretation of drug concentrations in an alternative matrix: the case of meprobamate in vitreous humor. Int J Legal Med 125(3):463–468. doi:10.​1007/​s00414-011-0560-y PubMedCrossRef
17.
Zurück zum Zitat Prouty RW, Anderson WH (1990) The forensic science implications of site and temporal influences on postmortem blood-drug concentrations. J Forensic Sci 35(2):243–270PubMed Prouty RW, Anderson WH (1990) The forensic science implications of site and temporal influences on postmortem blood-drug concentrations. J Forensic Sci 35(2):243–270PubMed
18.
Zurück zum Zitat Hoizey G, Gozalo C, Canas F, Fornes P, Binet L, Al T, Oget O, Millart H, Lamiable D (2008) Distribution tissulaire post-mortem du méprobamate: à propos de 8 cas. Ann Toxicol Anal 20(1):47–51CrossRef Hoizey G, Gozalo C, Canas F, Fornes P, Binet L, Al T, Oget O, Millart H, Lamiable D (2008) Distribution tissulaire post-mortem du méprobamate: à propos de 8 cas. Ann Toxicol Anal 20(1):47–51CrossRef
19.
Zurück zum Zitat Flanagan RJ (1998) Guidelines for the interpretation of analytical toxicology results and unit of measurement conversion factors. Ann Clin Biochem 35(Pt 2):261–267PubMed Flanagan RJ (1998) Guidelines for the interpretation of analytical toxicology results and unit of measurement conversion factors. Ann Clin Biochem 35(Pt 2):261–267PubMed
21.
Zurück zum Zitat Gaillard Y, Billault F, Pepin G (1997) Meprobamate overdosage: a continuing problem. Sensitive GC-MS quantitation after solid phase extraction in 19 fatal cases. Forensic Sci Int 86(3):173–180. doi:S0379073897021282 PubMedCrossRef Gaillard Y, Billault F, Pepin G (1997) Meprobamate overdosage: a continuing problem. Sensitive GC-MS quantitation after solid phase extraction in 19 fatal cases. Forensic Sci Int 86(3):173–180. doi:S037907389702128​2 PubMedCrossRef
22.
Zurück zum Zitat S. Jickells, A Negrusz (eds) (2008) Clarke’s analytical forensic toxicology. Pharmaceutical, London S. Jickells, A Negrusz (eds) (2008) Clarke’s analytical forensic toxicology. Pharmaceutical, London
23.
Zurück zum Zitat Takatori T, Tomii S, Terazawa K, Nagao M, Kanamori M, Tomaru Y (1991) A comparative study of diazepam levels in bone marrow versus serum, saliva and brain tissue. Int J Legal Med 104(4):185–188PubMedCrossRef Takatori T, Tomii S, Terazawa K, Nagao M, Kanamori M, Tomaru Y (1991) A comparative study of diazepam levels in bone marrow versus serum, saliva and brain tissue. Int J Legal Med 104(4):185–188PubMedCrossRef
24.
Zurück zum Zitat Watterson JH, Botman JE (2009) Detection of acute diazepam exposure in bone and marrow: influence of tissue type and the dose-death interval on sensitivity of detection by ELISA with liquid chromatography tandem mass spectrometry confirmation. J Forensic Sci 54(3):708–714. doi:10.1111/j.1556-4029.2009.00998.x PubMedCrossRef Watterson JH, Botman JE (2009) Detection of acute diazepam exposure in bone and marrow: influence of tissue type and the dose-death interval on sensitivity of detection by ELISA with liquid chromatography tandem mass spectrometry confirmation. J Forensic Sci 54(3):708–714. doi:10.​1111/​j.​1556-4029.​2009.​00998.​x PubMedCrossRef
Metadaten
Titel
Using bone marrow matrix to analyze meprobamate for forensic toxicological purposes
verfasst von
F. Bévalot
M. P. Gustin
N. Cartiser
Y. Gaillard
C. Le Meur
L. Fanton
J. Guitton
D. Malicier
Publikationsdatum
01.09.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
International Journal of Legal Medicine / Ausgabe 5/2013
Print ISSN: 0937-9827
Elektronische ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-013-0833-8

Weitere Artikel der Ausgabe 5/2013

International Journal of Legal Medicine 5/2013 Zur Ausgabe

Neu im Fachgebiet Rechtsmedizin

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …